Cytokine | Cohort | EC50, Dexamethasone | logEC50 ± S.E., Dexamethasone | Emax ± S.E.M., Dexamethasone | EC50, Resveratrol | logEC50 ± S.E., Resveratrol | Emax ± S.E.M., Resveratrol |
---|---|---|---|---|---|---|---|
M | % reduction | M | % reduction | ||||
IL-8 | NS | 2.4 × 10−7 | −6.628 ± 0.1552 | 58 ± 2.9 | 3.7 × 10−4 | −3.430 ± 0.1345 | 95 ± 17 |
S | 5.8 × 10−7 | −6.236 ± 0.3850 | 24 ± 4.3 | 4.7 × 10−4 | −3.330 ± 0.1640 | 95 ± 25 | |
COPD | – | – | – | 3.1 × 10−4 | −3.512 ± 0.1494 | 95 ± 18 | |
GM-CSF | NS | 2.3 × 10−9 | −8.640 ± 0.1488 | 95 ± 2.1 | 3.6 × 10−5 | −4.445 ± 0.0849 | 100 ± 3.6 |
S | 9.6 × 10−9 | −8.017 ± 0.1487 | 91 ± 2.9 | 3.3 × 10−5 | −4.480 ± 0.0961 | 100 ± 4.0 | |
COPD | 1.6 × 10−7 | −6.805 ± 0.0936 | 95 ± 2.7 | 4.2 × 10−6 | −5.381 ± 0.1081 | 97 ± 1.8 | |
VEGF | NS | 1.8 × 10−8 | −7.746 ± 0.1574 | 80 ± 2.3 | 1.6 × 10−5 | −4.787 ± 0.0813 | 98 ± 2.4 |
S | 3.2 × 10−8 | −7.496 ± 0.3331 | 71 ± 4.3 | 1.8 × 10−5 | −4.754 ± 0.1946 | 85 ± 4.9 | |
COPD | 2.3 × 10−8 | −7.629 ± 0.3986 | 73 ± 4.4 | 1.2 × 10−4 | −3.932 ± 0.1379 | 83 ± 8.2 |